Safety/Efficacy Study of SGN-15 (Antibody-Drug Conjugate) Combined With Gemcitabine in Patients With Ovarian Cancer
Clinical trial NCT00051584 · TERMINATED
Trial details
- NCT number
- NCT00051584
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.